Generation and characterization of anti-CD138 chimeric antigen receptor T (CAR-T) cells for the treatment of hematologic malignancies 

Development of a temozolomide-perillyl alcohol conjugate, NEO212, for the treatment of hematologic malignancies 

Genetic risk factors in multiple myeloma 

Anti-cancer effects of novel glidobactin type proteasome inhibitors 

Ancestral/Ethnic variation in the epidemiology and genetic predisposition of early-onset hematologic cancers 

Generation and characterization of fully human anti-CD19 chimeric antigen receptor T (CAR-T) cells for the treatment of hematologic malignancies 

Role of the bone marrow niche components in B cell malignancies 

The role of endoplasmic reticulum chaperones in regulating hematopoietic stem cells and hematological malignancies 

Characterization of epithelial-mesenchymal transition in acute myeloid leukemia 

Enhancing the specificity and cytotoxicity of chimeric antigen receptor Natural Killer cells 

Generation and characterization of humanized anti-CD19 chimeric antigen receptor T (CAR-T) cells for the treatment of hematologic malignancies 

Multimodal single-cell biology and machine learning to characterize plasma cell neoplasms 

Compliance with cancer chemotherapy: Implications for improvements in survival for patients with hematologic malignancy 

Genetic epidemiological approaches in the study of risk factors for hematologic malignancies 

The effect of renal function on toxicity of E7389 (eribulin) among patients with bladder cancer 

A synthetic lethal screen for NF-κB-dependent plasma cell disorders 

Maternal embryonic leucine zipper kinase (MELK) as a novel therapeutic target in the treatment of acute lymphoblastic leukemia 

Survival trends and related outcomes of survivors of childhood and young adult cancer 

Molecular strategies towards inhibition of KSHV-associated malignancies 

Characterization of upregulated adhesion GPCRs in acute myeloid leukemia 

The immunomodulatory effects of midostaurin on T cells 

The calcium-sensing receptor in the specification of normal and malignant hematopoietic cell localization in the bone marrow microenvironment 

Genomics and transcriptomic alterations of the glutamate receptors in acute myeloid leukemia 

Lym-1 epitope targeted chimeric antigen receptor (CAR) T cells for the immunotherapy of cancer 

Comparative analysis of scFv and non-scFv based chimeric antigen receptors (CARs) against B cell maturation antigen (BCMA)